Insider

Daniel Patrick O'Day

Chairman & CEO · Gilead Sciences, Inc. (GILD)

sold: $27,241,124

DateTradeSharesAvg. priceValueFiling
November 5, 2026Sale 10b5-1 plan112,429$175.16$19,693,439SEC
November 2, 2026Sale 10b5-1 plan30,881$172.57$5,329,178SEC
October 1, 2026Sale 10b5-1 plan15,000$147.90$2,218,508SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.